- Login
- Register & Subscribe
- Language: EN FR DE
Company News
Cell Medica expands management team
Saturday 9 March 2013
Just eight months after securing £17 million in new equity, Cell Medica Ltd has expanded its management team to appoint a chief medical officer, a chief financial officer and a vice president of development all of whom will be based in the US.
Location
United Kingdom
UK start-up to advance AD compound
Friday 8 March 2013
A new UK start-up based on technology from King’s College London has received funding from Advent Venture Partners. CoCo Therapeutics Ltd will progress an approach for Alzheimer’s disease that involves the retinoic acid receptor, RAR-alpha.
Location
United Kingdom
Electrical Geodesics to list on AIM
Friday 8 March 2013
A US medical technology company, Electrical Geodesics Inc (EGI), has announced plans to raise funds and seek admission to the London Stock Exchange’s Alternative Investment Market. EGI is based in Eugene, Oregon.
Location
United Kingdom
4SC AG chief executive steps down
Thursday 7 March 2013
Ulrich Dauer, a co-founder and the current chief executive and chair of the management board of 4SC AG, will be stepping down from his positions effective 31 March. Announcing the move on 6 March, the German company cited “personal reasons.”
Location
Germany
MorphoSys to raise R&D spending
Wednesday 6 March 2013
MorphoSys AG expects to increase spending on its proprietary antibody programmes this year after a reduction in investment in 2012 in order to push forward an in-licensed compound for cancer. It is also in active discussions to partner its antibody for RA.
Location
Germany
Trajenta won’t be launched in Germany - BI
Wednesday 6 March 2013
The Type-2 diabetes drug Trajenta (linagliptin) won’t be launched in Germany following a decision by the county’s reimbursement authority that it doesn’t provide any additional benefit compared with medicines already on the market.
Location
Germany
Australia strikes down AZ’s Crestor patents
Tuesday 5 March 2013
The Federal Court of Australia has upheld a challenge to AstraZeneca’s patents for the cholesterol medication, Crestor (rosuvastatin). The company said that it is reviewing its legal options which could include filing an appeal.
Location
United Kingdom
Humer to step down at Roche
Tuesday 5 March 2013
The Roche Group has announced that its former chief executive and current chairman of the board of directors, Franz Humer, will not be standing for re-election to the board in 2014. The company will nominate a successor in the autumn of 2013.
Location
Switzerland
Reaction to Elan’s dividend announcement muted
Tuesday 5 March 2013
After the directors of Elan Corporation proposed a dividend based on 20% of the company’s royalty revenues from its sale of the multiple sclerosis drug Tysabri to Biogen Idec, the stock market reaction was muted.
Location
Ireland
Diabetes project gets money
Saturday 2 March 2013
A stem-cell encapsulation product designed to treat people with insulin-dependent diabetes has received fresh funding, and according to the developer, could enter the clinic in 2014.
Location
United States
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013